Caregen케어젠
214370 · KOSDAQ · ₩214370 · 케어젠
- Market cap
- ₩1.8T
- Enterprise value
- ₩1.8T
- P/E
- 80.7×
- P/B
- 8.4×
- Dividend yield
- 1.3%
- ROE
- 10.5%
- Net margin
- 30.5%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−77.7% from the high
₩33,050Today: ₩33,550 – ₩35,350₩153,800
Returns
- 1W−11.9%
- 1M−13.5%
- 3M−31.4%
- 6M−67.6%
- YTD−52.2%
- 1Y−48.9%
- Volume today
- 55,624
- 0.8× the 20-day average
- Traded today
- ₩1.9B
- Listed shares
- 53,715,000
- EPS (12 months)
- ₩426
- Earnings yield 1.2%
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Quiet- BuzzQuietBuzz 39 of 100 (50 is a normal day for this stock).
- MomentumWeak-14.6% over the last month; the price is below its 20-day average.
Signals describe activity, not recommendations. Not financial advice.
Leveraged ETF flows
Estimated leveraged-ETF rebalance on Oct 28: buy ₩3B at the close (114.4% of 20-day average trading value)
On its 24 biggest days of the last 60 (moves of 3%+), the estimated pressure averaged 80.7% of trading value and pointed the same way 21 of 24 times.
- 2× KODEX KOSDAQ150 Leverage ₩2.7B
- -1× KODEX KOSDAQ150 Futures Inverse ₩152M
- 2× TIGER KOSDAQ150 Leverage ₩138M
- 2× RISE KOSDAQ150 Futures Leverage ₩26M
- -1× TIGER KOSDAQ150 Futures Inverse ₩5M
Mostly via futures: index funds hedge with KOSPI 200 / KOSDAQ 150 futures, spread here over the index's largest members by market value.
Final after the close. An intraday "if the close were now" estimate needs real-time prices, which we don't have yet.
Estimate based on ETF size and daily moves; actual trades may differ.
ETFs holding this
All ETFs →Held by 11 funds.
- KODEX KOSDAQ1500.7%
- KODEX KOSDAQ150 Leverage2×0.7%
- TIGER KOSDAQ1500.7%
- RISE KOSDAQ1500.7%
- TIGER KOSDAQ150 Leverage2×0.7%
- ACE KOSDAQ 1500.7%
- KIWOOM KOSDAQ1500.7%
- SOL KOSDAQ1500.7%
Estimated from the funds' index or underlying stock.
Futures and options
All stock futures →Futures (2026-11): 33,850
Basis −1.46% · implied rate −35.7%
Open interest 2,278 contracts
Futures and options can lose more than you put in. Figures describe the market; they are not predictions or recommendations. Paper trading only.
Caregen stock overview
Caregen (케어젠, KRX: 214370) is listed on KOSDAQ, in the Biotech & Pharma sector. Caregen is a Korean company that researches and develops biomimetic peptides and growth factor proteins, and sells medicines, health functional foods, medical devices, and cosmeceutical products based on them. Its shares closed at ₩34,350 on Oct 28, 2026, up 3.15% on the day, giving it a market value of ₩1.8T.
Key facts
- Market cap
- ₩1.8T
- Sector
- Biotech & Pharma
- Latest price change
- +3.15%
- As of
- Oct 28, 2026
- Main business
- Caregen is a Korean company that researches and develops biomimetic peptides and growth factor proteins, and sells medicines, health functional foods, medical devices, and cosmeceutical products based on them.
Quick answers about Caregen
- What does Caregen do?
- Caregen is a Korean company that researches and develops biomimetic peptides and growth factor proteins, and sells medicines, health functional foods, medical devices, and cosmeceutical products based on them. Its products include dermal fillers and mesotherapy treatments sold in about 130 countries, functional skincare and hair care products, and peptide and growth factor raw materials supplied to global customers such as BASF. The company is also developing peptide-based drug candidates for eye diseases, including macular degeneration and dry eye disease.
- What is the market cap of Caregen?
- The market capitalisation of Caregen was ₩1.8T at the close on Oct 28, 2026.
- Who are the largest shareholders of Caregen?
- According to the latest official filings, the largest reported holders are Jung Yong-ji (63.35%, as of Oct 1, 2026); National Pension Service (0.65%, as of Dec 31, 2025); VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND (0.39%, as of Jul 31, 2026).
- When is the next earnings report from Caregen?
- Korean companies rarely announce results dates in advance. Based on when Caregen filed the same report in past years, its next 3q results is expected between Nov 13, 2026 and Nov 14, 2026.
- Does the National Pension Service own Caregen?
- Yes. The National Pension Service held 0.65% of Caregen shares as of Dec 31, 2025.
Company profile
Caregen is a Korean company that researches and develops biomimetic peptides and growth factor proteins, and sells medicines, health functional foods, medical devices, and cosmeceutical products based on them. Its products include dermal fillers and mesotherapy treatments sold in about 130 countries, functional skincare and hair care products, and peptide and growth factor raw materials supplied to global customers such as BASF. The company is also developing peptide-based drug candidates for eye diseases, including macular degeneration and dry eye disease.
Written by AI from the company's latest annual report.
- Korean name
- 케어젠
- Sector
- Biotech & Pharma
- CEO
- 정용지
- Founded
- Aug 2001
- Listed
- Nov 2015
- Listed shares
- 53,715,000
- Fiscal year ends
- Month 12
- Website
- caregen.co.kr
Similar companies
- Samsung Biologics207940 · ₩64T₩1,372,000−0.15%
- Celltrion068270 · ₩44T₩189,800+0.64%
- Alteogen196170 · ₩16T₩223,000+2.06%
- SK biopharmaceuticals326030 · ₩5.9T₩75,200+0.40%
- Yuhan000100 · ₩5.7T₩77,300−3.38%
- HLB028300 · ₩5.4T₩40,650+1.88%
- Hanmi Pharm128940 · ₩4.7T₩369,500+5.42%
- SAM Chun Dang Pharm000250 · ₩4.5T₩190,000+1.28%
Recent filings
See all- Insider shareholding reportOct 1, 2026
- 5%+ holding reportSep 29, 2026
- 5%+ holding reportSep 28, 2026
- 5%+ holding reportSep 23, 2026
- Half-year report (Jun 2026)Aug 14, 2026
Titles in Korean until English translations are added.
Also known as: Caregen / 케어젠 / 214370 / KRX:214370
Source: KRX statistical information